DONATE

Search Results for:

Developing a new solution to treat atherosclerosis

We’ve all eaten rich meals or fatty foods and joked that we can feel our ‘arteries hardening’. However, the reality of atherosclerosis – when fat, cholesterol, and other substances build up in the artery walls and form solid structures called plaques – is no joking matter. The consequences of this disorder can include stroke and coronary artery disease, the leading cause of death in many developed countries.

Now, a new scientific project involving IBEC and three other European research centres is set to offer a novel, minimally-invasive treatment for atherosclerosis patients, thanks to funding awarded by the European Commission.

The classroom in the lab

Last week, IBEC welcomed a group of third year E.S.O. students from the Oak House School in Barcelona, who were taking part in the ESCOLAB initiative of the City Council of Barcelona.

“Un chip implantado bajo la piel libera fármacos a voluntad”

IBEC director and head of the Biomaterials for Regenerative Therapies group Josep Planell was quoted as an expert opinion last week in an article in La Vanguardia. The story covered a new chip developed at MIT able to release drugs under the skin while dosage and timing is controlled wirelessly.

New year, new name

IBEC director Josep Planell’s research group has changed its name and is now known as the Biomaterials for Regenerative Therapies group.

Biannual meeting of NanoMed Spain

Wednesday last week saw the biannual meeting at the institute of the steering committee of the Spanish NanoMedicine Platform (NanoMed Spain), which is coordinated by IBEC.

Reaching further

The Barcelona Science Park (PCB), where IBEC is located, has just launched a new multimedia platform to publicize the activities of the 75 companies and three research institutes working there.